Technical Analysis for GBIO - Generation Bio Co.

Grade Last Price % Change Price Change
F 30.25 -1.18% -0.36
GBIO closed down 1.18 percent on Friday, January 22, 2021, on 77 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical GBIO trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
20 DMA Support Bullish -1.18%
Inside Day Range Contraction -1.18%
Wide Bands Range Expansion -1.18%
Older End-of-Day Signals for GBIO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 19 hours ago
10 DMA Resistance about 19 hours ago
20 DMA Resistance about 20 hours ago
Down 3% about 20 hours ago
Down 2 % about 20 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Generation Bio Co. Description

Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Rare Diseases Emerging Technologies Molecular Biology Gene Therapy Manufacturing Process Lipid Applied Genetics Gene Delivery

Is GBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 55.72
52 Week Low 17.0
Average Volume 537,160
200-Day Moving Average 0.00
50-Day Moving Average 34.83
20-Day Moving Average 30.39
10-Day Moving Average 30.54
Average True Range 3.26
ADX 19.08
+DI 20.51
-DI 22.17
Chandelier Exit (Long, 3 ATRs ) 25.70
Chandelier Exit (Short, 3 ATRs ) 32.58
Upper Bollinger Band 36.71
Lower Bollinger Band 24.06
Percent B (%b) 0.49
BandWidth 41.62
MACD Line -0.85
MACD Signal Line -1.32
MACD Histogram 0.4735
Fundamentals Value
Market Cap 1.41 Billion
Num Shares 46.5 Million
EPS -1.13
Price-to-Earnings (P/E) Ratio -26.87
Price-to-Sales 0.00
Price-to-Book 7.86
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.65
Resistance 3 (R3) 32.57 31.68 32.25
Resistance 2 (R2) 31.68 31.07 31.73 32.12
Resistance 1 (R1) 30.97 30.69 30.53 31.05 31.98
Pivot Point 30.08 30.08 29.86 30.13 30.08
Support 1 (S1) 29.37 29.47 28.93 29.45 28.52
Support 2 (S2) 28.48 29.09 28.53 28.38
Support 3 (S3) 27.77 28.48 28.25
Support 4 (S4) 27.85